Vemlidy Tablet
Product Images NDC 61958-2301

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vemlidy (NDC 61958-2301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vemlidy 01)

Chemical structure diagram showing the molecular structure of the active ingredient tenofovir alafenamide, including its key functional groups and the presence of a 1/2 molar equivalent of an additional chemical component.*

FDA Label Image

Vemlidy-02.jpg (Vemlidy 02)

Label for Vemlidy (tenofovir alafenamide) 25 mg tablets, containing 30 tablets per container. The label includes storage instructions, a safety alert, and manufacturer information for Gilead Sciences, Inc. The product is made in Canada and is for oral use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.